Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease where the immune system mistakenly attacks healthy tissues and organs throughout the body. Unlike conditions diagnosed through physical examination alone, SLE requires specialized blood tests to confirm the diagnosis and monitor disease activity.
This is typically the first screening test for SLE. High levels of ANA (Antinuclear Antibodies) are often found in people with SLE. A positive ANA Screen with specific titer and pattern can indicate this autoimmune condition and guide further testing.
SLE symptoms can mimic many other conditions, making clinical diagnosis challenging. Blood tests are fundamental for detecting specific autoantibodies, measuring inflammation markers, and assessing immune system activity. These tests not only help confirm the diagnosis but also monitor disease progression and treatment response.
This is a key diagnostic marker specifically for SLE. The presence of anti-dsDNA antibodies indicates that the immune system is attacking the body's own DNA, leading to inflammation and tissue damage. High levels are often associated with active disease and can predict SLE flares.
SLE often results in lowered levels of C3c due to immune system overactivity. This test helps assess immune system consumption and can indicate the presence of an active disease flare, making it valuable for ongoing monitoring.
This test measures general inflammation in the body. Since SLE causes inflammation in various organs, an increased sedimentation rate suggests active inflammatory processes and helps monitor disease activity.
Up to 40% of SLE patients have cardiolipin antibodies. These antibodies can cause blood clotting problems and are associated with increased risk of complications including miscarriage, making this test important for comprehensive SLE management.
PCNA antibodies are found in a portion of SLE patients and indicate an ongoing autoimmune response where the immune system attacks healthy tissues. This test provides additional diagnostic confirmation in suspected cases.
High serum levels of IL-4 have been associated with SLE and may play a role in the dysregulated immune response characteristic of this autoimmune disease. This test helps assess immune system dysfunction.
In SLE, the presence of various antibodies and proteins can increase serum viscosity. This test helps assess blood flow properties and potential complications related to increased protein levels in the blood.
SLE diagnosis typically requires multiple positive tests along with clinical symptoms. No single test can definitively diagnose SLE, but the combination of specific autoantibodies, inflammation markers, and clinical presentation helps healthcare providers make an accurate diagnosis and develop appropriate treatment plans.
The information provided here is for educational purposes only and is not a substitute for professional medical advice. SLE is a complex autoimmune condition that requires ongoing medical supervision. Always consult with a healthcare provider for proper diagnosis, interpretation of test results, and treatment recommendations.